Philip Lambert
Chief Tech/Sci/R&D Officer chez SATELLOS BIOSCIENCE INC.
Fortune : - $ au 31/03/2024
Profil
Philip Lambert was the founder of Vivopath LLC, a company founded in 2008, where he held the title of Chief Scientific Officer from 2008 to 2017.
He is currently the Chief Scientific Officer at Satellos Bioscience, Inc. since 2022.
In his former positions, Dr. Lambert worked as a Scientific Partner & Head-Discovery at Charles River Laboratories, Inc., as a Senior Vice President-Discovery & Labs at Life Biosciences, Inc., and as the Chief Scientific Officer at Centogene NV from 2019 to 2021.
He also served as the Chief Operating Officer at Spotlight Biosciences, Inc. Dr. Lambert obtained a doctorate degree from Imperial College London and an undergraduate degree from The University of Liverpool.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
SATELLOS BIOSCIENCE INC
-.--% | 01/06/2023 | 0 ( -.--% ) | - $ | 31/03/2024 |
Postes actifs de Philip Lambert
| Sociétés | Poste | Début |
|---|---|---|
| SATELLOS BIOSCIENCE INC. | Chief Tech/Sci/R&D Officer | 27/09/2022 |
Anciens postes connus de Philip Lambert
| Sociétés | Poste | Fin |
|---|---|---|
| CENTOGENE N.V. | Chief Tech/Sci/R&D Officer | 16/08/2021 |
Vivopath LLC
 Vivopath LLC BiotechnologyHealth Technology Part of Charles River Laboratories International, Inc., Vivopath LLC is a private company engaged in discovery services specializing in the rapid, in vivo compound evaluation of molecules in the therapeutic areas of metabolism, inflammation, and oncology. The company is based in Worcester, MA. The company was founded by Philip Lambert. Vivopath was acquired by Charles River Laboratories International, Inc. on June 30, 2014 for $2.30 million. | Founder | 01/12/2017 |
Life Biosciences, Inc.
 Life Biosciences, Inc. Electronic Equipment/InstrumentsElectronic Technology Life Biosciences, Inc. engages in the provision of research on aging and age-related diseases. It focuses on altered communication and inflammation, chromosomal instability, cellular senescence, loss of protoeostasis, metabolism, stem cell exhaustion, epigenetic alterations, and mitochondrial dysfunction. The company was founded by David Sinclair and Tristan Alexander Edwards in 2017 and is headquartered in Boston, MA. | Corporate Officer/Principal | - |
Charles River Laboratories, Inc.
 Charles River Laboratories, Inc. Miscellaneous Commercial ServicesCommercial Services Charles River Laboratories, Inc. provides research models and laboratory animal support services. It offers quality research models and support services to the biomedical community. The company was founded in 1947 and is headquartered in Wilmington, MA. | Corporate Officer/Principal | - |
| Spotlight Biosciences, Inc. | Chief Operating Officer | - |
Formation de Philip Lambert
| Imperial College London | Doctorate Degree |
| The University of Liverpool | Undergraduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 2 |
|---|---|
| CENTOGENE N.V. | Commercial Services |
| SATELLOS BIOSCIENCE INC. | Health Technology |
| Entreprise privées | 4 |
|---|---|
Charles River Laboratories, Inc.
Charles River Laboratories, Inc. Miscellaneous Commercial ServicesCommercial Services Charles River Laboratories, Inc. provides research models and laboratory animal support services. It offers quality research models and support services to the biomedical community. The company was founded in 1947 and is headquartered in Wilmington, MA. | Commercial Services |
Vivopath LLC
Vivopath LLC BiotechnologyHealth Technology Part of Charles River Laboratories International, Inc., Vivopath LLC is a private company engaged in discovery services specializing in the rapid, in vivo compound evaluation of molecules in the therapeutic areas of metabolism, inflammation, and oncology. The company is based in Worcester, MA. The company was founded by Philip Lambert. Vivopath was acquired by Charles River Laboratories International, Inc. on June 30, 2014 for $2.30 million. | Health Technology |
Life Biosciences, Inc.
Life Biosciences, Inc. Electronic Equipment/InstrumentsElectronic Technology Life Biosciences, Inc. engages in the provision of research on aging and age-related diseases. It focuses on altered communication and inflammation, chromosomal instability, cellular senescence, loss of protoeostasis, metabolism, stem cell exhaustion, epigenetic alterations, and mitochondrial dysfunction. The company was founded by David Sinclair and Tristan Alexander Edwards in 2017 and is headquartered in Boston, MA. | Electronic Technology |
| Spotlight Biosciences, Inc. |
